The history of Viagra and its effect on the pharmaceutical sector presents a intricate question regarding its continued appeal as an investment. Initially a blockbuster success, generating vast revenues, generic competition has significantly eroded earnings . While major pharmaceutical firms maintain patents on related therapies and investigate new

The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced significant volatility. Investors are now facing the consequences of rival medications , d